The Role of CMOs in Indian Pharma Exports: What Traders and Buyers Should Know
India's pharmaceutical industry has a well-developed Contract Manufacturing Organisation (CMO) sector — manufacturers who produce pharmaceutical products on behalf of other companies (brand owners, traders, and export houses) rather than or in addition to marketing products under their own name. Understanding the CMO model helps buyers understand how Indian pharmaceutical traders like Bharat Medex are able to cover a wide product range without owning manufacturing facilities.
---
What Is a CMO?
A Contract Manufacturing Organisation (CMO) — sometimes also called a Contract Development and Manufacturing Organisation (CDMO) when development services are included — is a manufacturing company that produces pharmaceutical products under contract for a client, typically:
- The client (brand owner, trader, or export house) provides the product formula, specifications, and often the regulatory file - The CMO manufactures the product at their licensed facility - The product may be sold under the client's brand name or the CMO's product licence, depending on the arrangement
In the Indian pharma context, CMO relationships are pervasive — many products traded under various brand names are manufactured at the same CMO facilities.
---
Why CMOs Matter for the Indian Pharma Export Landscape
Range without capital intensity: A trader or mid-sized pharma company can offer a broad product range by working with multiple CMOs — one for oral solids, one for injectables, one for topicals — without investing in multiple manufacturing facilities. This is the commercial model that enables traders to serve diverse buyer requirements. Manufacturing capacity access: CMOs compete on quality, price, and capacity. The market forces behind CMO relationships drive manufacturing efficiency and, increasingly, quality investment. Speed to market: For a trader seeking to source a specific generic molecule for an export market, engaging a CMO can be faster than waiting for a brand manufacturer to supply — especially for less common molecules.---
Types of CMO Arrangements in Indian Pharma
Loan Licence Manufacturing (Third-Party Manufacturing): India's regulatory framework includes a loan licence provision under the Drugs & Cosmetics Act, which allows a company to manufacture drugs at another licensed manufacturer's premises. The loan licencee (the brand owner or trader) holds a separate licence that covers manufacture at the CMO's facility. This is a common arrangement for branded generic products. Toll Manufacturing: A company provides raw materials (API and excipients) to a manufacturer who processes and packages them. The manufacturer charges a "toll" (service fee) for the manufacturing work. Full CMO (Spec manufacturing): The CMO uses its own raw material sourcing and manufactures to the client's specifications, supplying finished product.---
Quality Considerations in CMO-Based Supply
For buyers procuring products that originate from CMO manufacturing:
GMP certification travels with the facility, not the brand: The WHO-GMP, EU-GMP, or other quality certification belongs to the manufacturing facility (the CMO). When your supplier says "this product is manufactured at a WHO-GMP certified facility," verify the GMP certificate covers the specific CMO facility producing your product. Manufacturer consistency matters: Ask your supplier whether the manufacturing facility is consistent across orders. CMO changes between orders can introduce variability — request notification of any manufacturing site change and confirmation that the new facility holds equivalent GMP certification. Loan licence products and labelling: For loan licence products, the label may show both the brand owner and the manufacturing facility address, or only the brand owner with "manufactured at" details. This can create confusion when matching product labels to GMP certificates — confirm with your supplier.---
What to Ask Your Supplier
When sourcing products through an Indian pharmaceutical trader:
1. Is this product manufactured at your own facility or a CMO? (Transparency on this point is a positive sign) 2. What is the name and address of the manufacturing facility? 3. Can you provide the manufacturing facility's current GMP certificate? 4. Is there a loan licence or toll manufacturing arrangement, and if so, under whose drug licence is the product released?
---
Bharat Medex works with manufacturers across India's pharma ecosystem — including both own-brand manufacturers and CMO-based producers — to source products across our ethical, generic, and surgical range. We are transparent about our sourcing arrangements and provide manufacturer details and GMP certificates as part of our standard documentation package.
Contact us to discuss sourcing arrangements for your specific requirements.
0 comments